The IdentRA® test panel detects Rheumatoid Arthritis (RA) earlier than traditional blood tests by combining 14-3-3η protein with RF and anti-CCP. The 14-3-3η protein identifies 21% of early RA and 67% of established RA patients who test negative for RF and anti-CCP blood tests.
CEO Michael Lohscheller shares an important message to #NKLA stockholders urging them to vote FOR each proposal for the Annual Meeting on June 7, 2023.